Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C-Reference-Cited by-同舟云学术

Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C

Published:2002-11 Issue:5 Volume:36 Page:1273-1279
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Soza Alejandro,Everhart James E.,Ghany Marc G.,Doo Edward,Heller Theo,Promrat Kittichai,Park Yoon,Liang T. Jake,Hoofnagle Jay H.

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1053/jhep.2002.36502/fullpdf

Reference21 articles.

1. The epidemiology of viral hepatitis in the United States;Alter;Gastroenterol Clin North Am,1994

2. Ten-year follow-up after interferon-alpha therapy for chronic hepatitis C;Lau;Hepatology,1998

3. Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach;Camma;J Hepatol,2001

4. A comparative trial of recombinant interferon alpha 2a versus alpha 2b on myelosuppression in healthy adult volunteers;Wong;Hepatogastroenterology,1996

5. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial;Manns;Lancet,2001

Cited by 175 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Type I Interferon Orchestrates Demand-Adapted Monopoiesis during Influenza A Virus Infection via STAT1-Mediated Upregulation of Macrophage Colony-Stimulating Factor Receptor Expression;Journal of Virology;2023-04-27

2. Large-scale in vivo CRISPR screens identify SAGA complex members as a key regulators of HSC lineage commitment and aging;2022-07-22

3. Development of highly stable and de-immunized versions of recombinant alpha interferon: Promising candidates for the treatment of chronic and emerging viral diseases;Clinical Immunology;2021-12

4. Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infection;BMC Infectious Diseases;2020-12

5. EASL recommendations on treatment of hepatitis C: Final update of the series☆;Journal of Hepatology;2020-11